1 – 10 of 357
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
(
- Contribution to journal › Article
-
Mark
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
2024) In Annals of Allergy, Asthma and Immunology(
- Contribution to journal › Article
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
(
- Contribution to journal › Article
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
(
- Contribution to journal › Article
-
Mark
Disease burden and unmet need for acute allergic reactions – A patient perspective
(
- Contribution to journal › Article
-
Mark
Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP : A Brief Overview of Pathophysiology and Recent Clinical Insights
(
- Contribution to journal › Article
- 2023
-
Mark
Multidisciplinary approaches to identifying and managing global airways disease : Expert recommendations based on qualitative discussions
(
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
-
Mark
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
(
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter